Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science

被引:492
作者
Ahles, Tim A. [1 ]
Root, James C. [1 ]
Ryan, Elizabeth L. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10022 USA
关键词
CEREBRAL WHITE-MATTER; BREAST-CANCER; ADJUVANT CHEMOTHERAPY; NEUROPSYCHOLOGICAL PERFORMANCE; LONGITUDINAL ASSESSMENT; SYSTEMIC CHEMOTHERAPY; BRAIN STRUCTURE; SURVIVORS; IMPAIRMENT; WOMEN;
D O I
10.1200/JCO.2012.43.0116
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cognitive changes associated with cancer and cancer treatments have become an increasing concern. Using breast cancer as the prototype, we reviewed the research from neuropsychological, imaging, genetic, and animal studies that have examined pre- and post-treatment cognitive change. An impressive body of research supports the contention that a subgroup of patients is vulnerable to post-treatment cognitive problems. We also propose that models of aging may be a useful conceptual framework for guiding research in this area and suggest that a useful perspective may be viewing cognitive change in patients with cancer within the context of factors that influence the trajectory of normal aging.
引用
收藏
页码:3675 / 3686
页数:12
相关论文
共 78 条
  • [1] Adjuvant chemotherapy for breast cancer: Effects on cerebral white matter seen in diffusion tensor imaging
    Abraham, Jame
    Haut, Marc W.
    Moran, Maria T.
    Filburn, Shannon
    Lemiuex, Susan
    Kuwabara, Hiroto
    [J]. CLINICAL BREAST CANCER, 2008, 8 (01) : 88 - 91
  • [2] The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy
    Ahles, TA
    Saykin, AJ
    Noll, WW
    Furstenberg, CT
    Guerin, S
    Cole, B
    Mott, LA
    [J]. PSYCHO-ONCOLOGY, 2003, 12 (06) : 612 - 619
  • [3] Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma
    Ahles, TA
    Saykin, AJ
    Furstenberg, CT
    Cole, B
    Mott, LA
    Skalla, K
    Whedon, MB
    Bivens, S
    Mitchell, T
    Greenberg, ER
    Silberfarb, PM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) : 485 - 493
  • [4] Ahles TA, 2010, PSYCHO-ONCOLOGY, P251
  • [5] Ahles TA, 2010, CLIN PSYCHOONOCLOGY
  • [6] Cognitive function in breast cancer patients prior to adjuvant treatment
    Ahles, Tim A.
    Saykin, Andrew J.
    McDonald, Brenna C.
    Furstenberg, Charlotte T.
    Cole, Bernard F.
    Hanscom, Brett S.
    Mulrooney, Tamsin J.
    Schwartz, Gary N.
    Kaufman, Peter A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (01) : 143 - 152
  • [7] Candidate mechanisms for chemotherapy-induced cognitive changes
    Ahles, Tim A.
    Saykin, Andrew J.
    [J]. NATURE REVIEWS CANCER, 2007, 7 (03) : 192 - 201
  • [8] Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve
    Ahles, Tim A.
    Saykin, Andrew J.
    McDonald, Brenna C.
    Li, Yuelin
    Furstenberg, Charlotte T.
    Hanscom, Brett S.
    Mulrooney, Tamsin J.
    Schwartz, Gary N.
    Kaufman, Peter A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4434 - 4440
  • [9] Neurocognitive Late Effects of Chemotherapy in Children: The Past 10 Years of Research on Brain Structure and Function
    Anderson, Fiona S.
    Kunin-Batson, Alicia S.
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 52 (02) : 159 - 164
  • [10] Cognitive impairment associated with adjuvant therapy in breast cancer
    Bender, Catherine M.
    Sereika, Susan M.
    Berga, Sarah L.
    Vogel, Victor G.
    Brufsky, Adam M.
    Paraskar, Karen K.
    Ryan, Christopher M.
    [J]. PSYCHO-ONCOLOGY, 2006, 15 (05) : 422 - 430